Rydex Energy Services Fund Class H
RYVAX
NASDAQ
| Weiss Ratings | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B- | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Rydex Funds | |||
| Manager/Tenure (Years) | Michael P. Byrum (27), Adrian Bachman (3), Brendan Cain (3), 2 others | |||
| Website | http://www.guggenheiminvestments.com | |||
| Fund Information | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Rydex Energy Services Fund Class H | |||
| Category | Equity Energy | |||
| Sub-Category | Energy Sector Equity | |||
| Prospectus Objective | Specialty - Natural Resources | |||
| Inception Date | Apr 02, 1998 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.44% | |||
| Dividend | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.33% | |||
| Asset Allocation | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.00% | |||
| Stock | 99.88% | |||
| U.S. Stock | 94.84% | |||
| Non-U.S. Stock | 5.04% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.12% | |||
| Price History | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.10% | |||
| 30-Day Total Return | 5.94% | |||
| 60-Day Total Return | 17.87% | |||
| 90-Day Total Return | 37.56% | |||
| Year to Date Total Return | 42.52% | |||
| 1-Year Total Return | 75.02% | |||
| 2-Year Total Return | 18.69% | |||
| 3-Year Total Return | 45.50% | |||
| 5-Year Total Return | 88.80% | |||
| Price | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $293.65 | |||
| 1-Month Low NAV | $268.01 | |||
| 1-Month High NAV | $304.91 | |||
| 52-Week Low NAV | $141.15 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $304.91 | |||
| 52-Week High Price (Date) | Mar 27, 2026 | |||
| Beta / Standard Deviation | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.88 | |||
| Standard Deviation | 31.22 | |||
| Balance Sheet | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 14.14M | |||
| Operating Ratios | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.63% | |||
| Turnover Ratio | 431.00% | |||
| Performance | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | -2.60% | |||
| Last Bear Market Total Return | -19.81% | |||